A patient on hydrochlorothiazide develops hyponatraemia; which medication could contribute via SIADH?

Prepare for the American Board of Family Medicine Examination. Test your knowledge with flashcards and multiple choice questions, each with explanations and hints. Ready yourself for success!

Multiple Choice

A patient on hydrochlorothiazide develops hyponatraemia; which medication could contribute via SIADH?

Explanation:
The main idea is drug-induced SIADH, where there is excess release or action of ADH causing water retention and dilutional hyponatremia. Carbamazepine is a classic cause of SIADH: it increases ADH secretion and/or the renal response to ADH, leading to euvolemic hyponatremia. In a patient already taking hydrochlorothiazide, which promotes sodium loss, this SIADH effect can worsen the drop in serum sodium. The other medications listed are not typically associated with SIADH as a primary mechanism, so they don’t commonly produce this pattern of hyponatremia.

The main idea is drug-induced SIADH, where there is excess release or action of ADH causing water retention and dilutional hyponatremia. Carbamazepine is a classic cause of SIADH: it increases ADH secretion and/or the renal response to ADH, leading to euvolemic hyponatremia. In a patient already taking hydrochlorothiazide, which promotes sodium loss, this SIADH effect can worsen the drop in serum sodium. The other medications listed are not typically associated with SIADH as a primary mechanism, so they don’t commonly produce this pattern of hyponatremia.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy